TMCI - Treace Medical Concepts, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
141,838
141,838
94,419
57,365
39,416
Cost of revenue
27,523
27,523
17,826
12,470
7,631
Gross profit
114,315
114,315
76,593
44,895
31,785
Operating expenses
Research development
13,584
13,584
10,204
5,847
5,070
Selling general and administrative
135,575
135,575
82,899
38,193
30,250
Total operating expenses
149,159
149,159
93,103
44,040
35,320
Operating income or loss
-34,844
-34,844
-16,510
855
-3,535
Interest expense
4,398
4,398
4,060
2,777
841
Total other income/expenses net
-4,483
-4,483
-
-
-
Income before tax
-42,815
-42,815
-20,552
-3,668
-4,265
Income from continuing operations
-42,815
-42,815
-20,552
-3,668
-4,265
Net income
-42,815
-42,815
-20,552
-3,668
-4,265
Net income available to common shareholders
-42,815
-42,815
-20,748
-4,308
-4,905
Basic EPS
-
-
-0.43
-0.10
-0.11
Diluted EPS
-
-
-0.43
-0.10
-0.11
Basic average shares
-
-
48,416
43,903
43,903
Diluted average shares
-
-
48,416
43,903
43,903
EBITDA
-
-36,284
-15,807
319
-2,631